Form 4: Tevogen Bio Holdings Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Neal Flomenberg, Chief Scientific Officer of Tevogen Bio Holdings, sold shares to cover tax obligations related to vesting of restricted stock units.
Summary
- On March 12, 2025, Neal Flomenberg, the Chief Scientific Officer of Tevogen Bio Holdings Inc., sold 232,968 shares of common stock.
- The sales were executed to satisfy tax obligations related to the vesting and settlement of restricted stock units.
- The shares were sold at a weighted average price of $1.09, with individual transactions ranging from $1.05 to $1.12.
- Following the transaction, Flomenberg still beneficially owns 3,595,608 shares of Tevogen Bio Holdings Inc.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) and does not contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares by company officers to cover tax obligations are a common occurrence, especially after vesting of restricted stock units. This is a normal part of executive compensation and financial planning.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date of the transaction (sale of shares). |
| 03/14/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.